WhyPeptides

ClinicalTrials.gov research-record information

ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Nashville, TN

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 22 results; after an exact city/state check of listed facilities, 22 records were retained for Nashville, Tennessee. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
Nashville, Tennessee
Exact-location inclusion rule
A listed facility city and state must match Nashville, Tennessee.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
8 records
NOT_YET_RECRUITING
2 records
ACTIVE_NOT_RECRUITING
11 records
ENROLLING_BY_INVITATION
1 record

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 22 exact-location records and 6 listed facilities. All 22 retained records are shown below.

NCT07564414

Registry title: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research AssociatesNashville, Tennessee 37203

NCT06143956

Registry title: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Quality Medical ResearchNashville, Tennessee 37211

NCT07112872

Registry title: A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research AssociatesNashville, Tennessee 37203

NCT04822181

Registry title: Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Quality Medical ResearchNashville, Tennessee 37211

NCT06075667

Registry title: A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt Health One Hundred OaksNashville, Tennessee 372212

NCT05254314

Registry title: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37203

NCT05726227

Registry title: A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37212

NCT07642635

Registry title: Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37232

NCT07639021

Registry title: A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research AssociatesNashville, Tennessee 37203

NCT06534411

Registry title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research AssociatesNashville, Tennessee 37203

NCT06162715

Registry title: GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Study-level overall status
ENROLLING_BY_INVITATION
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37209

NCT07221214

Registry title: GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37232

NCT06651177

Registry title: Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37232

NCT06965413

Registry title: A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research AssociatesNashville, Tennessee 37203

NCT03811561

Registry title: A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt Diab Obes Clin TriNashville, Tennessee 37212

NCT05390892

Registry title: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37232

NCT06037252

Registry title: A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research Associates IncNashville, Tennessee 37203

NCT06338553

Registry title: GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37232

NCT07011667

Registry title: A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Clinical Research AssociatesNashville, Tennessee 37203

NCT07115069

Registry title: Comparison of Body Composition Changes With Weight Loss Interventions

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37232

NCT06603571

Registry title: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Quality Medical ResearchNashville, Tennessee 37211

NCT06901245

Registry title: Tirzepatide in PWS, HO and GNSO

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Vanderbilt University Medical CenterNashville, Tennessee 37203

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 22 results. After an exact city/state check of listed facilities, 22 records were retained for Nashville, Tennessee, across 6 listed facilities. All 22 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
22
Exact-location records retained
22
Listed facilities retained
6
Records shown
22 of 22
Fixed ClinicalTrials.gov source query (JSON) Broader live ClinicalTrials.gov search (no status filter)

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.